Individualized altered fractionation as a more effective radiotherapy for non-small cell lung cancer

被引：2
|
作者：
Chen, Yi-Jen [1 ]
机构：
[1] City Hope Med Ctr, Duarte, CA 90603 USA
来源：
JOURNAL OF THORACIC DISEASE | 2014年 / 6卷 / 07期
关键词：
D O I：
10.3978/j.issn.2072-1439.2014.06.39
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：E161 / E162
页数：2
相关论文
共 50 条
  • [41] Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer
    Erman, M
    Moretti, L
    Soria, JC
    Le Chevalier, T
    Van Houtte, P
    SEMINARS IN RADIATION ONCOLOGY, 2004, 14 (04) : 315 - 321
  • [42] Hedgehog Inhibitor and Radiotherapy in Non-small Cell Lung Cancer
    Zeng, J.
    Aziz, K.
    Aftab, B.
    Armour, M.
    Chettair, S.
    Gajula, R.
    Salih, T.
    Rudin, C.
    Tran, P. T.
    Hales, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S737 - S737
  • [43] Moderately hypofractionated radiotherapy in non-small cell lung cancer
    Fajardo Paneque, I.
    Tisaire Sanchez, J. L.
    Diaz Gomez, L.
    Macias Lozano, M. J.
    Jaen Olasolo, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S969 - S970
  • [44] Altered fractionation radiotherapy in lung cancer
    Palazzi, M
    Cerrotta, A
    Villa, S
    TUMORI, 1998, 84 (02) : 171 - 175
  • [45] Localized non-small cell lung cancer: Adjuvant radiotherapy in the era of effective systemic therapy
    Bogart, JA
    Aronowitz, JN
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5004S - 5010S
  • [46] Dose and Fractionation for Immunomodulation in SBRT of non-small cell Lung Cancer
    Gkika, E.
    Firat, E.
    Adebahr, S.
    Popp, I.
    Radicioni, G.
    Exner, J.
    Ruehle, A.
    Tanja, S.
    Nicolay, N. H.
    Nestle, U.
    Niedermann, G.
    Duda, D. G.
    Grosu, A. L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S14 - S14
  • [47] Immunotherapy in non-small cell lung cancer: steps towards more effective combination therapies
    Rosenbaum, Matthew W.
    Mino-Kenudson, Mari
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S774 - S778
  • [48] LAZERTINIB IS SAFE AND EFFECTIVE IN NON-SMALL CELL LUNG CANCER
    不详
    CANCER DISCOVERY, 2019, 9 (12) : 1645 - 1645
  • [49] Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC)
    Mascaux, Celine
    Ekman, Simon
    Dooms, Christophe
    Shepherd, Frances A.
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (01) : 1 - 9
  • [50] Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC)
    Celine Mascaux
    Simon Ekman
    Christophe Dooms
    Frances A. Shepherd
    Current Respiratory Care Reports, 2013, 2 (1): : 1 - 9
12345